A New Horizon of Atopic Dermatitis Therapy

Patients with atopic dermatitis struggle with ongoing challenges when trying to manage this chronic condition. Their symptoms can be disruptive, and some treatments can cause new problems for them to handle. Patients with skin of color often face unique challenges caused by missed diagnoses and negative side effects of traditional treatments. New therapeutic agents, including biologics and JAK inhibitors, can help these patients to manage their symptoms without the negative side effects they have experienced with other treatments, but appropriate use of these new therapies presents its own set of challenges.

A New Horizon of Atopic Dermatitis Therapy was designed by a multidisciplinary team of allergist/immunologists, dermatologists, advanced practitioners, and patients to help allergist/immunologists and  dermatologists, as well as advanced practitioners and nurses working in these clinical settings, to support their patients with atopic dermatitis to navigate the new treatment options that are now available, while incorporating patients and their quality of life concerns in the process of selecting the best therapy for each patient.

This course will take approximately two and one-half hours to complete. Then, after a 30 day wait period, you will be invited to complete a follow-up assessment that will qualify you to satisfy the practice improvement requirement of the ABAI's Maintenance of Certification program.

A New Horizon of Atopic Dermatitis Therapy is funded through an educational grant from Pfizer.

Target Audience

  • Allergist/Immunologists
  • Dermatologists
  • Primary Care Providers
  • Fellows-in-Training
  • Nurses and Nurse Practitioners
  • Physician Assistants and Other Allied Health Professionals 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Determine the appropriate treatment for patients with AD
  • Evaluate the risks and benefits of biologics of JAK inhibitors, including their mechanisms of action, when be used in the treatment and care of patients with AD
  • Identify opportunities to engage the patient in developing a treatment plan for AD that addresses their unique circumstances, including quality of life and socioeconomic factors


aaaai_logo                             axdev_logo

Available credit: 
  • 2.50 Attendance
    Attendance credit.
  • 2.50 CE
    CE credit.
  • 2.50 CME
    CME credit.
Course opens: 
Course expires: 

Anna Fishbein, MD MS FAAAAI
Anna Fishbein, MD, MS is Associate Professor of Pediatrics in the Division of Allergy & Immunology at Ann & Robert H. Lurie Children's Hospital/Northwestern University Feinberg School of Medicine. She completed her undergraduate degree at Washington University in St. Louis and medical degree at the University of Chicago Pritzker School of Medicine. Her post graduate medical training was at Lurie Children’s/Northwestern University for both Pediatric residency and Allergy/Immunology Fellowship. This was complemented by a Master of Science in Clinical Investigation she completed at Northwestern during her fellowship training. Dr. Fishbein’s research and clinical focus is on atopic dermatitis (eczema). Her laboratory studies circadian mechanisms of nocturnal eczema flare, as well as the impact of these flares on sleep, attention and quality of life. Her goal is to transform the clinical science of pediatric eczema care.

Relevant Relationships: None



Edith Schussler, MD
Dr. Edith Schussler is a board-certified Allergist and Immunologist and an Assistant Professor of Pediatrics at Weill Cornell Medical College. Dr. Schussler received her undergraduate degree at the University of California Berkeley, before completing premedical studies at Harvard University. A native New Yorker, she returned to New York to attend the Icahn School of Medicine at Mount Sinai, where she also completed her residency in pediatrics and fellowship in adult and pediatric Allergy and Immunology. Dr. Schussler received grants from the Jeffery Modell Foundation and the United States Immunodeficiency Network to support her fellowship research. She has presented her immunology research at the European Society for Immunodeficiencies, The Clinical Immunology Society, the American Academy of Allergy Asthma & Immunology, and the American College of Allergy Asthma & Immunology. She has published on immune dysregulation in Gaucher disease, allergy to Botulinum antitoxin, food allergy and primary immunodeficiency and has recently completed a Chapter on Anaphylaxis for 5th edition of Hall, Schmidt, and Wood’s Principles of Critical Care.  She is an active member of the American Academy of Asthma Allergy and Immunology, New York Asthma Allergy Society and Clinical Immunology Society.  Her areas of expertise include primary immunodeficiency, allergy, food allergy, food protein induced enterocolotis (FPIES), food protein induced proctocolitis, allergic rhinitis, allergic asthma, immunotherapy, chronic hives, and atopic dermatitis.

Relevant Relationships: None


Raj Chovatiya, MD PhD
Raj Chovatiya, MD PhD is Assistant Professor of Dermatology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr. Chovatiya received his M.D. and Ph.D. in immunology from Yale University. He completed his internship at Yale followed by residency and postdoctoral research fellowship at Northwestern, where he also served as Chief Resident. Dr. Chovatiya directs the Center for Eczema and Itch at Northwestern, and his clinical focus includes atopic dermatitis, eczema, chronic itch, and other chronic inflammatory skin disorders including seborrheic dermatitis, psoriasis, hidradenitis, and vitiligo. Dr. Chovatiya’s research interests include optimizing patient-centered care, understanding chronic disease burden, and improving care across diverse skin types. He has published numerous abstracts and manuscripts, and has been recognized for his contributions as a speaker, researcher, and leader at national and international conferences.

Relevant Relationships:
AbbVie, Arcutis, L'Oreal, Beiersdorf, Bristol Myers Squibb, Dermavant, EPI Health, Incyte, National Eczema Association, Pfizer, Regeneron, Sanofi, UCB : consultant;
AbbVie, Eli Lilly, Incyte, Pfizer, Regeneron, Sanofi, UCB : speaker



Megan Ott Lewis, MSN CRNP
Megan is a Pediatric Nurse Practitioner at the Children's Hospital of Philadelphia and has practiced in the division of Allergy & Immunology since 2009. She was graduated by the University of Virginia for both undergraduate and graduate degrees.  After graduation, completed a LEND fellowship in neurodevelopmental disabilities.  She also the Program Manager for the Food Allergy Center which received funding to expand care, both clinical and research, for programs such as Oral Food Challenges, Oral Immunotherapy and leads a clinic focused on anxiety around food allergies- the Food Allergy Bravery Clinic.  She has spoken locally and nationally on topics related to allergic diseases. She was selected for the inaugural Advanced Practice Provider clinical recognition program as a Clinical Leader Master, the highest level.

Relevant Relationships: None


Ayesha Lemons
My name is Ayesha Lemons.  I was diagnosed with severe eczema at a very early age in life.  I am now in my forties and still have symptoms of eczema.  My son also has been diagnosed with severe eczema and is on biweekly biologic medication for it.  We are happy to provide insights about this from a patient's and caregiver's perspective.

Relevant Relationships: None



Christina Barnes, CPNP-PC
Christina is a freelance medical writer and pediatric nurse practitioner with 10 years of healthcare experience. She has worked in pediatric and neonatal critical care, pediatric surgery, and pediatric primary care.

Relevant Relationships: None



Robert Corriel, MD FAAAAI
Lake Success Allergy and Clinical Immunology, Lake Success, NY
Relevant relationships: None

Anne Russell, MS BSN RN AE-C
Spring Arbor University, Spring Arbor, MI
Relevant relationships: None

Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 2.50 Contact Hours.

ABAI Maintenance of Certification 

The American Board of Allergy and Immunology (ABAI) accepts this activity to meet the practice improvement requirements of Part IV of their Maintenance of Certification program. Learn more about ABAI Part IV Quality Improvement Activities.

ABD Continuing Certification

This exercise has been reviewed and approved by the American Board of Dermatology for Continuing Certification (MOC) Practice Improvement credit and 25 Self-Assessment credits.

AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.


Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 2.50 Attendance
    Attendance credit.
  • 2.50 CE
    CE credit.
  • 2.50 CME
    CME credit.
Activity Title
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.


Please login or register to take this course.

Please click on the first module Foundations of Atopic Dermatitis from the list above to begin.

By registering for this educational activity you are confirming that you have read the Privacy and Data Protection Notice and agree to the terms as outlined below:

Privacy and Data Protection Notice

The American Academy of Allergy, Asthma & Immunology (AAAAI) takes your privacy seriously. AAAAI will only use your personal information to administer your registration, attendance, and credit claiming/attendance record for this activity, to provide services that you have requested from AAAAI and otherwise as you may expressly consent. A complete copy of AAAAI’s Legal and Privacy Notices, the terms of which are incorporated herein, can be found here.

By providing consent, you are allowing AAAAI to process your personal data. AAAAI will collect and store information you provide in the Registration/Housing Forms for the purposes of enabling us to register your attendance at the activity; to assist with administrative, planning and marketing purposes; and to allow the compilation and analysis of statistics relevant to AAAAI.

The information you provide in the Registration/Housing Forms, and information provided at any other time during this activity, including without limitation any feedback obtained during the activity, will be used by AAAAI to offer, provide and continue to improve its educational activities and other services. The AAAAI will also use your email address to communicate important information regarding this activity and for marketing purposes for future activities. AAAAI will not otherwise, without your consent, use or disclose your personal information for any purpose unless it would reasonably be expected that such a purpose is related to the offer, provision and improvement of the activity or where such purpose is permitted or required by law.

For courses/events with industry support and/or exhibitors, The AAAAI may disclose some information that is collected in the Registration Form such as your name, credentials, title/position, organization, and mailing address to exhibitors and industry supporters for marketing purposes such as to receive mailed literature. In addition to, but separate from, your consent regarding being contacted by exhibitors and industry supporters with mailed literature, when you visit sponsored areas within the virtual platform for an online event (such as, but not limited to, an exhibitor’s virtual exhibit booth), that organization will receive your personal contact information (name, credentials, title/position, organization, mailing address, phone number, email address and NPI number, if applicable). If you do not want to share your personal contact information with any/all of those organizations, please do not visit those areas within our virtual platform. By accessing any/all of those areas in our virtual platform, you are consenting to share your personal contact information with all organizations whose sponsored areas you visit in our virtual platform. If you attend this activity in person, and provide your contact information to an exhibitor or industry supporter (including allowing them to scan your name badge), you are consenting to share your personal contact information with that organization. You have the right to decline an exhibitor and/or industry supporter’s request for your personal contact information. AAAAI does not control the use or distribution of personal contact information transferred when you visit a sponsored area in the virtual platform or, if in person, when you share your personal contact information, and as such, AAAAI shall not be held responsible for any misuse of your personal data obtained by exhibitors or industry supporters in this manner. You have the right to ask the exhibitor or industry supporter questions about how they will use your personal data, how long it will be retained and if they will share information with third parties.

After you have submitted your personal contact information in the registration form, you may change your preferences for receiving emails by following the instructions below:
·    To change your preferences for receiving emails from AAAAI regarding future annual meetings and/or other in-person and online education programs, please visit http://aaaai.execinc.com/edibo/Profile
·    For events where industry support or exhibitions are involved please email cme@aaaai.org to change your consent to be contacted by the industry supporters and exhibitors of that activity.

NOTE: AAAAI  may be photographing this activity. These photographs, along with your name, may be used in AAAAI publications or on the AAAAI website. If you do not want your photo used, please inform the staff photographer at the time the photograph is taken. AAAAI may also be audio recording education sessions during this activity. If you verbally submit any questions for Question & Answer sessions (Q&A), you are agreeing to be recorded and to have that recording available in enduring materials. If you prefer not to be audio recorded, please submit any questions you have in writing.

I understand that it is my right to withhold consent to the above Privacy and Data Protection Notice, or to withdraw my previous consent at any time. I further understand that without my consent, it is not possible to process my registration/housing request for this activity. Please contact the AAAAI Education Team at (414) 272-6071 if you have any further questions about how this will affect your registration/housing request for this activity.

Required Hardware/software

One of the two latest versions of Google Chrome, Microsoft Edge, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.